PTGS2 and neoplasm: Recent studies have shown a close association between iNOS and COX-2 activity in HNSCC and tumor angiogenesis and metastasis of lymph nodes, so iNOS and COX-2 inhibitors have been proposed as potential antitumor drugs with a strong antiangiogenic effect [116, 117].